LivingGLP1
Study S000638

Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University

ClinicalTrials.gov record

Registration

Registration
NCT06256419
Study type
INTERVENTIONAL
Masking
NONE
Status
RECRUITING
Enrollment
300
Start
2024-01-01
Primary completion
2028-01-31
Lead sponsor
The Affiliated Hospital of Xuzhou Medical University
Conditions
Type 2 Diabetes Mellitus; Susceptibility, Genetic
Interventions
DRUG:GLP-1 receptor agonist; DRUG:responders group and nonresponders group
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Change from baseline HbA1c and baseline weight at 6 month [6 month after GLP-1 RA treatment]
  • To identify and evaluate the variable factors influencing GLP-1 RA efficacy [1 month after sample integration]
  • Genotype identification in patients with T2DM [1 month after sample collecting]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.